Loading…
Rapidly Rising Prevalence of Nosocomial Multidrug‐Resistant, Gram‐Negative Bacilli: A 9‐Year Surveillance Study
To examine and quantify the temporal trends of nosocomial multidrug-resistant, gram-negative bacilli. A 9-year surveillance study was conducted. Multidrug resistance was defined as resistance to 3 or more antimicrobial classes. Tertiary-care institution. From 1994 to 2002, multidrug-resistant, gram-...
Saved in:
Published in: | Infection control and hospital epidemiology 2004-10, Vol.25 (10), p.842-846 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | To examine and quantify the temporal trends of nosocomial multidrug-resistant, gram-negative bacilli.
A 9-year surveillance study was conducted. Multidrug resistance was defined as resistance to 3 or more antimicrobial classes.
Tertiary-care institution.
From 1994 to 2002, multidrug-resistant, gram-negative bacilli increased from 1% to 16% for multidrug-resistant Pseudomonas aeruginosa, 4% to 13% for multidrug-resistant Enterobacter species, 0.5% to 17% for multidrug-resistant Klebsiella species, 0% to 9% for multidrug-resistant Proteus species, and 0.2% to 4% for multidrug-resistant Escherichia coli (P < or = .05). The most common pattern of multidrug resistance was co-resistance to quinolones, third-generation cephalosporins, and aminoglycosides.
The rapid rise of multidrug-resistant, gram-negative bacilli may warrant infection control programs to include these pathogens in strategies aimed at limiting the emergence and spread of antimicrobial-resistant pathogens. |
---|---|
ISSN: | 0899-823X 1559-6834 |
DOI: | 10.1086/502306 |